MLEC
Moolec Science S.A.
NASDAQ · Healthcare · Biotechnology · LU
$6.93
−2.94%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 1.16x
- P/E 2028E
- 0.23x
- P/S forward
- 4.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.16x
- Price / sales
- 1.84x
- Price / cash flow
- -2.53x
Enterprise value
- Enterprise value
- $34.6M
- EV / sales
- 4.41x
- EV / EBITDA
- -6.63x
- EV / EBIT
- -3.78x
- Market cap
- $14.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2025